Skip to main content
Contact Us
Subscribe
E-Edition
93°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Forma Therapeutics Holdings Inc
(NQ:
FMTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 13, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
19.98 (496)
Ask (Size)
20.01 (1,384)
Prev. Close
20.01
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
47,852,557
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech Stocks Well-Positioned For The Fourth Quarter
October 12, 2022
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Via
Talk Markets
Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes
October 03, 2022
Via
Benzinga
Performance
More News
Read More
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease
September 30, 2022
From
Forma Therapeutics, Inc.
Via
Business Wire
FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX
September 27, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
4 Analysts Have This to Say About Forma Therapeutics Hldgs
September 02, 2022
Via
Benzinga
Recap: Forma Therapeutics Q2 Earnings
August 05, 2022
Via
Benzinga
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
Via
Investor's Business Daily
Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11
September 11, 2022
Via
Talk Markets
FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX
September 02, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022
September 02, 2022
Via
Benzinga
This Analyst Predicts $700 For Broadcom, Plus RBC Capital Slashes PT On This Stock By 85%
September 02, 2022
Via
Benzinga
Dow Turns Higher; Gold Down 1%
September 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 01, 2022
Via
Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
Via
Benzinga
Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply
September 01, 2022
Via
Benzinga
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
September 01, 2022
Via
Benzinga
Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout
September 01, 2022
Via
Investor's Business Daily
Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday
September 01, 2022
Via
Benzinga
Guardforce AI (GFAI) Stock Gets a Boost From New Exec Team
September 01, 2022
Via
InvestorPlace
Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News
September 01, 2022
Via
InvestorPlace
After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal
September 01, 2022
Via
Benzinga
FMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Forma Therapeutics, Holdings Inc. Is Fair to Shareholders
September 01, 2022
From
Halper Sadeh LLP
Via
Business Wire
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders
September 01, 2022
From
Forma Therapeutics
Via
Business Wire
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
August 05, 2022
From
Forma Therapeutics Holdings, Inc.
Via
Business Wire
Earnings Scheduled For August 5, 2022
August 05, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.